Nadège Gaborit

964 total citations
24 papers, 773 citations indexed

About

Nadège Gaborit is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Nadège Gaborit has authored 24 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Nadège Gaborit's work include HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nadège Gaborit is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nadège Gaborit collaborates with scholars based in France, Israel and Slovakia. Nadège Gaborit's co-authors include Moshit Lindzen, Yosef Yarden, André Pèlegrin, Christel Larbouret, Thierry Chardès, D. Azria, Pierre Gillet, Caroline Mollévi, Laurent Grossin and Patrick Netter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Nadège Gaborit

23 papers receiving 757 citations

Peers

Nadège Gaborit
Hitomi Sudo Japan
Diane V. Lefley United Kingdom
Rajeshwari R. Valiathan United States
W. D. W. Heston United States
Rachele Alzani Italy
Dina Leitão Portugal
Hannah K. Brown United Kingdom
Zohreh Varasteh Sweden
Fa Yang China
Yang Feng United States
Hitomi Sudo Japan
Nadège Gaborit
Citations per year, relative to Nadège Gaborit Nadège Gaborit (= 1×) peers Hitomi Sudo

Countries citing papers authored by Nadège Gaborit

Since Specialization
Citations

This map shows the geographic impact of Nadège Gaborit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Gaborit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Gaborit more than expected).

Fields of papers citing papers by Nadège Gaborit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Gaborit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Gaborit. The network helps show where Nadège Gaborit may publish in the future.

Co-authorship network of co-authors of Nadège Gaborit

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Gaborit. A scholar is included among the top collaborators of Nadège Gaborit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Gaborit. Nadège Gaborit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garambois, Véronique, Nadège Gaborit, Christel Larbouret, et al.. (2020). Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking. Cancer Science. 111(7). 2508–2525. 3 indexed citations
2.
Romaniello, Donatella, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.. (2020). Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers. 12(9). 2394–2394. 40 indexed citations
3.
4.
Ogier, Charline, Pierre‐Emmanuel Colombo, Corinne Bousquet, et al.. (2018). Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Letters. 432. 227–236. 43 indexed citations
5.
Dahlhoff, Maik, Nadège Gaborit, Sebastian Bultmann, et al.. (2017). CRISPR‐assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes. FEBS Journal. 284(19). 3339–3349. 13 indexed citations
6.
Mancini, Maicol, Hilah Gal, Nadège Gaborit, et al.. (2017). An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors. EMBO Molecular Medicine. 10(2). 294–308. 42 indexed citations
7.
Gaborit, Nadège, Ali Abdul‐Hai, Maicol Mancini, et al.. (2015). Examination of HER3 targeting in cancer using monoclonal antibodies. Proceedings of the National Academy of Sciences. 112(3). 839–844. 35 indexed citations
8.
Larbouret, Christel, Nadège Gaborit, Marie‐Alix Poul, André Pèlegrin, & Thierry Chardès. (2015). Le récepteur HER3 ou ERBB3. médecine/sciences. 31(5). 465–468.
9.
Capparelli, Claudia, Sheera R. Rosenbaum, Lisa D. Berman-Booty, et al.. (2015). ErbB3–ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas. Cancer Research. 75(17). 3554–3567. 18 indexed citations
10.
Chardès, Thierry, Nadège Gaborit, Caroline Mollévi, et al.. (2014). HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models. Oncotarget. 5(16). 7138–7148. 38 indexed citations
11.
Ferraro, Daniela A., Nadège Gaborit, Ruth Maron, et al.. (2013). Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR. Proceedings of the National Academy of Sciences. 110(5). 1815–1820. 93 indexed citations
12.
Lazrek, Yassamine, Olivier Dubreuil, Véronique Garambois, et al.. (2013). Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation. Neoplasia. 15(3). 335–IN40. 35 indexed citations
13.
Ho-Pun-Cheung, Alexandre, Hervé Bazin, Nadège Gaborit, et al.. (2012). Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer. PLoS ONE. 7(7). e37065–e37065. 21 indexed citations
14.
15.
Gaborit, Nadège, Christel Larbouret, Frédéric Peyrusson, et al.. (2011). Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers. Journal of Biological Chemistry. 286(13). 11337–11345. 58 indexed citations
16.
Pinzano, Astrid, S. Étienne, Laurent Grossin, et al.. (2006). Increased apoptosis in rat osteoarthritic cartilage corresponds to degenerative chondral lesions and concomitant expression of caspase-3. Biorheology. 43(3-4). 403–412. 7 indexed citations
17.
Grossin, Laurent, Christel Henrionnet, Astrid Pinzano, et al.. (2006). Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. The FASEB Journal. 20(1). 65–75. 56 indexed citations
18.
Dumas, Dominique, Nadège Gaborit, Laurent Grossin, et al.. (2004). Spectral and lifetime fluorescence imaging microscopies: New modalities of multiphoton microscopy applied to tissue or cell engineering. Biorheology. 41(3-4). 459–467. 11 indexed citations
19.
Grossin, Laurent, S. Étienne, Nadège Gaborit, et al.. (2004). Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo. Biorheology. 41(3-4). 521–534. 32 indexed citations
20.
Grossin, Laurent, Nadège Gaborit, Lluis M. Mir, Patrick Netter, & Pierre Gillet. (2003). Gene therapy in cartilage using electroporation. Joint Bone Spine. 70(6). 480–482. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitomi Sudo Breakdown of academic impact, for papers by Diane V. Lefley Breakdown of academic impact, for papers by Rajeshwari R. Valiathan Breakdown of academic impact, for papers by W. D. W. Heston Breakdown of academic impact, for papers by Rachele Alzani Breakdown of academic impact, for papers by Dina Leitão Breakdown of academic impact, for papers by Hannah K. Brown Breakdown of academic impact, for papers by Zohreh Varasteh Breakdown of academic impact, for papers by Fa Yang Breakdown of academic impact, for papers by Yang Feng
Rankless by CCL
2026